biotin

Biotin, also known as vitamin B7 or vitamin H, is a water‑soluble vitamin that belongs to the B‑complex family. Chemically, it consists of an ureido ring fused with a tetrahydrothiophene ring, with a valeric acid side chain, enabling it to act as an essential cofactor for several carboxylase enzymes that are critical to metabolism. Biotin is widely present in food, synthesized by intestinal bacteria, and routinely absorbed in the small intestine when freed from dietary proteins by biotinidase. In the US and many Western populations, average dietary biotin intake has been estimated between 35 and 70 mcg per day due to its presence in common foods, such as liver, eggs, legumes, nuts, and seeds. Biotin differs from many other vitamins in that when taken in supplemental form even at high doses, absorption remains efficient, and excess is excreted in urine. Unlike many other vitamins, biotin does not have a traditionally established RDA because scientific evidence is insufficient to establish a requirement that meets the needs of almost all healthy individuals. Instead, Adequate Intake (AI) values were developed based on observed intakes in healthy populations. The AI for adults is set at 30 mcg per day. Biotin functions as a coenzyme for five carboxylases: acetyl‑CoA carboxylase 1 and 2, pyruvate carboxylase, propionyl‑CoA carboxylase, and methylcrotonyl‑CoA carboxylase, each of which plays a central role in energy metabolism, fatty acid synthesis, and gluconeogenesis. These biochemical processes underscore biotin’s essential role in converting nutrients from food into usable energy and building blocks for cellular structures. Biotin’s critical nature has historical roots; deficiencies were first described in the context of "egg white injury," where raw egg white intake led to dermal and metabolic abnormalities, later shown to be due to avidin binding and inactivating biotin. Today, despite adequate intake among most healthy individuals, biotin's biochemical significance persists across metabolism, gene regulation, and across all living cells, where it is essential for normal growth and development.

Biotin’s primary biological role is as a cofactor for carboxylase enzymes, each of which plays integral roles in essential metabolic pathways. Specifically, biotin serves as a prosthetic group that enables carboxylases to catalyze key reactions in fatty acid synthesis (via acetyl‑CoA carboxylases), branched‑chain amino acid catabolism (via methylcrotonyl‑CoA carboxylase), gluconeogenesis (via pyruvate carboxylase), and odd‑chain fatty acid metabolism (via propionyl‑CoA carboxylase). These enzymatic activities ensure that the body can effectively derive energy from fats, carbohydrates, and proteins, making biotin indispensable for cellular energy homeostasis. Emerging research is expanding our understanding of biotin beyond classical metabolic pathways. For instance, recent studies suggest a role for biotin in gene regulation via biotinylation of histones, which may influence chromatin dynamics, gene expression, and cellular differentiation. The molecular biology of biotin underscores its multifaceted contributions beyond basic nutrition, with potential implications for understanding metabolic disorders and cellular physiology. While the evidence base for biotin’s effects on beauty outcomes such as hair, skin, or nails is limited, small clinical reports suggest that supplementation can benefit individuals with brittle nails or rare hair disorders, though these findings require further rigorous research. It is crucial to interpret such results cautiously, as large randomized controlled trials demonstrating definitive benefits for cosmetic concerns in the general population are lacking. Biotin is also being investigated for its potential roles in clinical contexts such as multiple sclerosis and metabolic dysfunction, with early findings indicating possible modulation of cellular energy pathways, though data remain preliminary. These broader health implications underline biotin’s foundational role in human biology while highlighting the need for targeted research to verify specific therapeutic claims.

Because biotin’s dietary requirement has not been precisely defined through controlled depletion‑repletion studies, institutions like the Food and Nutrition Board use Adequate Intake (AI) values rather than Recommended Dietary Allowances (RDA). AI values are established when evidence is insufficient to derive an EAR and RDA but are judged sufficient to ensure nutritional adequacy in healthy populations. For biotin, the AI for adults aged 19 and older is 30 micrograms per day, with the same AI applied to both men and women. Pregnant people are also recommended to consume 30 micrograms per day, while lactation increases the AI slightly to 35 micrograms per day. For infants (0–12 months), AI values range from 5 to 6 micrograms daily, reflecting developmental needs, while children’s AIs increase progressively with age, from 8 mcg (1–3 years) to 20 mcg (9–13 years). Adolescents aged 14–18 years have an AI set at 25 micrograms per day. These AI recommendations aim to prevent clinical deficiency and support normal growth and metabolism. It is important to recognize that dietary patterns, age, health status, and conditions such as pregnancy can influence biotin needs. Pregnancy, for instance, is associated with changes in biomarkers of biotin metabolism, and approximately half of pregnant women exhibit signs of marginal biotin deficiency in controlled diets, though the clinical significance of this remains under study. Most people achieve adequate biotin status through a varied diet. Unlike fat‑soluble vitamins, biotin is water‑soluble and is not stored extensively in the body, necessitating consistent intake. Factors such as gastrointestinal disorders that impair absorption, prolonged antibiotic use disrupting gut microbiota synthesis, or genetic disorders affecting biotin recycling can increase requirements or necessitate supplementation. In practice, biotin intake should be considered within the context of total diet quality. Foods naturally rich in biotin, such as organ meats, eggs, legumes, nuts, and seeds, can help meet AI levels without the need for routine supplementation in healthy individuals.

Biotin deficiency is uncommon in populations consuming balanced diets because biotin is widely distributed in foods and synthesized by intestinal bacteria. Nevertheless, when deficiency occurs, it can present with distinct clinical features. Early signs of marginal deficiency often involve the integumentary and nervous systems and include hair thinning or loss (alopecia), erythematous skin rashes often concentrated around the eyes, nose, and mouth, and brittle nails. Dermatological manifestations may also include seborrheic dermatitis or generalized dermatitis. Because biotin acts as a cofactor in fatty acid metabolism, inadequate activity of carboxylases can impair cell membrane integrity, contributing to these cutaneous and nail abnormalities. Deficiency symptoms can also extend to neuromuscular complaints such as fatigue, muscle weakness, lethargy, mood changes, and cognitive disturbances. In severe cases, especially in individuals with genetic disorders like biotinidase deficiency or holocarboxylase synthetase deficiency, neurological symptoms can progress to seizures, developmental delay, ataxia, or hypotonia. Biotinidase deficiency, a rare autosomal recessive enzymatic disorder discovered through newborn screening programs, impairs the release of biotin from dietary proteins and normal metabolic recycling, leading to systemic deficiency despite normal intake. Diagnostic testing for biotin deficiency is challenging because direct blood biotin levels do not reliably reflect marginal status; functional indicators such as urinary excretion of biotin metabolites and decreased activity of biotin‑dependent enzymes are often used instead. Importantly, some populations are at increased risk, including individuals receiving prolonged intravenous feeding without adequate biotin, those with gastrointestinal malabsorption, and people on long‑term anticonvulsant therapy, which may reduce biotin status. Prompt identification and high‑dose supplementation can reverse many signs of deficiency, but irreversible neurological damage can occur if treatment is delayed in congenital forms.

A wide variety of foods contain biotin, enabling most individuals to meet their daily needs through diet. Organ meats, especially liver, rank among the richest sources; for example, chicken liver provides exceptionally high biotin levels per serving. Other animal sources include egg yolks, which deliver significant biotin amounts when cooked, as cooking inactivates avidin in raw egg whites that otherwise binds biotin and inhibits absorption. Fish such as salmon contributes biotin along with beneficial omega‑3 fatty acids and protein. Legumes like soybeans and peanuts offer plant‑based options with appreciable biotin content, making them valuable for vegetarian diets. Nuts and seeds, including roasted sunflower seeds and almonds, contribute moderate biotin amounts and can be easily integrated into snacks or meals. Whole grains and pseudocereals such as rye and amaranth also contribute biotin, though in lower concentrations compared with organ meats. Vegetables such as sweet potatoes and broccoli provide additional biotin along with fiber, vitamins, and antioxidants, supporting overall dietary quality. Herbal and spice sources like ground basil and mustard powder contain notable biotin levels on a per‑weight basis but are typically consumed in smaller quantities. The bioavailability of biotin from foods is generally high, particularly when foods are cooked, which reduces components like avidin that can inhibit absorption. A varied eating pattern that includes both animal and plant sources helps ensure adequate intake. Fortified foods may also supply biotin, although biotin is not commonly added to many fortified products compared to other B vitamins. Together, these diverse food sources support meeting the daily adequate intake without reliance on supplements in most healthy individuals.

Biotin absorption occurs primarily in the small intestine after dietary biotin is released from food proteins by the enzyme biotinidase. Biotinidase cleaves biotin from dietary protein‑bound forms, enabling free biotin to be absorbed efficiently. In supplemental form, free biotin does not require prior cleavage and is absorbed nonsaturably across the jejunum, meaning even relatively high supplemental doses are absorbed effectively. Factors enhancing absorption include cooking foods to deactivate biotin‑binding proteins such as avidin found in raw egg whites. Conversely, consuming raw egg whites can impair biotin absorption because avidin binds biotin with high affinity, preventing uptake. The intestinal microbiota also synthesizes biotin, and a portion of this microbially derived biotin may be absorbed and contribute to overall status. Bioavailability of biotin from different food matrices can vary, but generally, the vitamin is well‑absorbed from both animal and plant sources. Protein‑rich foods tend to facilitate biotin uptake, reflecting the food matrix’s influence on digestion and enzyme activity. Because biotin is water‑soluble, it dissolves readily in the aqueous environment of the gastrointestinal tract, and its absorption is not highly dependent on the presence of dietary fat, unlike fat‑soluble vitamins. Once absorbed, biotin circulates bound to plasma proteins or in free form, and excess biotin is excreted in urine. Factors that may impair absorption include conditions that affect small intestinal mucosa, such as celiac disease or inflammatory bowel disease, and prolonged antibiotic use, which may disrupt gut bacterial synthesis. In clinical practice, ensuring adequate intake from bioavailable food sources remains foundational for maintaining biotin status.

Most people can obtain adequate biotin through diet due to its widespread occurrence in foods and efficient absorption. Supplements may be considered for individuals with documented deficiency, specific medical conditions, or increased needs. Genetic disorders such as biotinidase deficiency and holocarboxylase synthetase deficiency require lifelong biotin supplementation at pharmacologic doses to prevent severe metabolic and neurologic complications. In such cases, doses far exceeding dietary intake are medically necessary and effective. Supplementation is also sometimes promoted for cosmetic reasons, such as improving hair, skin, or nail health. While anecdotal reports and small studies suggest some benefit in individuals with brittle nails or specific disorders, robust clinical evidence supporting widespread cosmetic use in people with normal biotin levels is limited. Routine use of high‑dose biotin for beauty outcomes without deficiency is not strongly supported by clinical research, and healthcare providers generally advise against unnecessary supplementation. When supplementation is appropriate, common forms include biotin tablets, capsules, or multivitamin complexes. Typical supplemental doses for deficiency may range from 1 to 10 mg daily under medical supervision, significantly higher than daily intake from food. Timing of intake can coincide with meals to integrate it into daily routine, though absorption is not highly dependent on food presence. Choosing high‑quality supplements from reputable manufacturers with third‑party testing helps ensure product purity and label accuracy. Individuals considering supplementation, especially at higher doses, should consult a healthcare provider to assess needs, monitor status, and avoid possible interactions or interference with diagnostic tests.

Biotin has a low risk of toxicity due to its water‑soluble nature, meaning excess intake is typically excreted in urine rather than stored. The Food and Nutrition Board and NIH do not establish a tolerable upper intake level (UL) for biotin because evidence of adverse effects at high intake levels is lacking. However, extremely high supplemental doses, far above dietary intake, can cause unintended consequences, particularly interference with laboratory assays. Elevated blood biotin levels from supplements can distort immunoassays that rely on biotin‑streptavidin interactions, affecting measurements of hormones such as thyroid hormones or markers such as cardiac troponin, leading to inaccurate results. Although conventional toxicity symptoms like organ damage have not been documented with excessive biotin consumption, high supplemental intake without medical indication is not recommended. Mild side effects reported with supplemental use include gastrointestinal discomfort or skin rashes in rare cases. Because there is no established UL, healthcare providers may use clinical judgment to guide safe use, especially when patients are undergoing diagnostic testing that could be skewed by high biotin levels. Awareness and disclosure of biotin supplement use to healthcare providers and laboratory personnel help mitigate the risk of inaccurate test results. In general, maintaining intake within dietary ranges from food sources supports health without the risks associated with pharmacologic doses.

Biotin generally has limited direct drug interactions. However, certain medications may lower biotin levels or be affected by its presence. Anticonvulsant drugs used for epilepsy, such as carbamazepine and phenobarbital, have been associated with reduced biotin status due to increased metabolism, calling for monitoring and possible supplemental biotin in long‑term use. Other medications, such as antibiotics that disrupt gut microbiota, may theoretically impact intestinal biotin synthesis and uptake. High supplemental biotin can interfere with diagnostic laboratory tests using biotin‑streptavidin technology, including assays for thyroid hormones, cardiac markers like troponin, and reproductive hormones, potentially leading to incorrect clinical interpretations. Awareness of biotin use is essential prior to such testing, allowing labs to adjust protocols or advise temporary cessation of supplements before testing. Interactions with other nutrients are generally minimal, though long‑term high‑dose supplemental use alongside other nutrient manipulations should be monitored for overall nutrient balance. Communication between patients and healthcare providers about all medications, supplements, and health conditions helps ensure safe and effective clinical care.

Common Forms: tablets, capsules, multivitamin complexes

Typical Doses: 30 mcg daily (dietary), therapeutic up to mg doses under medical supervision

When to Take: with meals if preferred

Best Form: free biotin (D‑biotin)

⚠️ Interactions: anticonvulsants (e.g., carbamazepine), antibiotics affecting gut microbiota